197 related articles for article (PubMed ID: 36181864)
1. Metabolic alterations of short-chain fatty acids and TCA cycle intermediates in human plasma from patients with gastric cancer.
Kim YL; Lee W; Chung SH; Yu BM; Lee YC; Hong J
Life Sci; 2022 Nov; 309():121010. PubMed ID: 36181864
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry.
Yu L; Aa J; Xu J; Sun M; Qian S; Cheng L; Yang S; Shi R
J Gastroenterol Hepatol; 2011 Aug; 26(8):1290-7. PubMed ID: 21443661
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of short-chain fatty acids in human plasma and serum by GC-MS.
Yao L; Davidson EA; Shaikh MW; Forsyth CB; Prenni JE; Broeckling CD
Anal Bioanal Chem; 2022 Jun; 414(15):4391-4399. PubMed ID: 35091760
[TBL] [Abstract][Full Text] [Related]
4. Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease.
Thing M; Werge MP; Kimer N; Hetland LE; Rashu EB; Nabilou P; Junker AE; Galsgaard ED; Bendtsen F; Laupsa-Borge J; McCann A; Gluud LL
BMC Gastroenterol; 2024 Jan; 24(1):43. PubMed ID: 38262952
[TBL] [Abstract][Full Text] [Related]
5. An optimized analytical method for cellular targeted quantification of primary metabolites in tricarboxylic acid cycle and glycolysis using gas chromatography-tandem mass spectrometry and its application in three kinds of hepatic cell lines.
Xu J; Zhai Y; Feng L; Xie T; Yao W; Shan J; Zhang L
J Pharm Biomed Anal; 2019 Jul; 171():171-179. PubMed ID: 31005043
[TBL] [Abstract][Full Text] [Related]
6. Fast quantification of short-chain fatty acids in rat plasma by gas chromatography.
Wang CY; Chen YW; Tain YL; Chang SKC; Huang LT; Hsieh CW; Hou CY
J Food Sci; 2020 Jun; 85(6):1932-1938. PubMed ID: 32449963
[TBL] [Abstract][Full Text] [Related]
7. Short-chain fatty acids reprogram metabolic profiles with the induction of reactive oxygen species production in human colorectal adenocarcinoma cells.
Huang C; Deng W; Xu HZ; Zhou C; Zhang F; Chen J; Bao Q; Zhou X; Liu M; Li J; Liu C
Comput Struct Biotechnol J; 2023; 21():1606-1620. PubMed ID: 36874158
[TBL] [Abstract][Full Text] [Related]
8. Development of simultaneous quantitative analysis of tricarboxylic acid cycle metabolites to identify specific metabolites in cancer cells by targeted metabolomic approach.
Yamamoto T; Sato K; Yamaguchi M; Mitamura K; Taga A
Biochem Biophys Res Commun; 2021 Dec; 584():53-59. PubMed ID: 34768082
[TBL] [Abstract][Full Text] [Related]
9. Metabolic signature of
Meiller L; Sauvinet V; Breyton AE; Ranaivo H; Machon C; Mialon A; Meynier A; Bischoff SC; Walter J; Neyrinck AM; Laville M; Delzenne NM; Vinoy S; Nazare JA
Eur J Nutr; 2023 Sep; 62(6):2633-2648. PubMed ID: 37222787
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers.
Son MY; Cho HS
J Microbiol Biotechnol; 2023 Jul; 33(7):849-856. PubMed ID: 37100764
[TBL] [Abstract][Full Text] [Related]
11. GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy.
Li M; Wang X; Aa J; Qin W; Zha W; Ge Y; Liu L; Zheng T; Cao B; Shi J; Zhao C; Wang X; Yu X; Wang G; Liu Z
Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1317-24. PubMed ID: 23467425
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and Optimization of Sample Handling Methods for Quantification of Short-Chain Fatty Acids in Human Fecal Samples by GC-MS.
Hsu YL; Chen CC; Lin YT; Wu WK; Chang LC; Lai CH; Wu MS; Kuo CH
J Proteome Res; 2019 May; 18(5):1948-1957. PubMed ID: 30895795
[TBL] [Abstract][Full Text] [Related]
13. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
14. Effects of whole-grain cereal foods on plasma short chain fatty acid concentrations in individuals with the metabolic syndrome.
Vetrani C; Costabile G; Luongo D; Naviglio D; Rivellese AA; Riccardi G; Giacco R
Nutrition; 2016 Feb; 32(2):217-21. PubMed ID: 26706023
[TBL] [Abstract][Full Text] [Related]
15. Short-chain fatty acids in diseases.
Zhang D; Jian YP; Zhang YN; Li Y; Gu LT; Sun HH; Liu MD; Zhou HL; Wang YS; Xu ZX
Cell Commun Signal; 2023 Aug; 21(1):212. PubMed ID: 37596634
[TBL] [Abstract][Full Text] [Related]
16. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
[TBL] [Abstract][Full Text] [Related]
17. Assessing the progression of gastric cancer via profiling of histamine, histidine, and bile acids in gastric juice using LC-MS/MS.
Lee W; Um J; Hwang B; Lee YC; Chung BC; Hong J
J Steroid Biochem Mol Biol; 2020 Mar; 197():105539. PubMed ID: 31730800
[TBL] [Abstract][Full Text] [Related]
18. Determination of the intermediates in glycolysis and tricarboxylic acid cycle with an improved derivatization strategy using gas chromatography-mass spectrometry in complex samples.
Li W; Huo J; Berik E; Wu W; Hou J; Long H; Lei M; Li Z; Zhang Z; Wu W
J Chromatogr A; 2023 Mar; 1692():463856. PubMed ID: 36803770
[TBL] [Abstract][Full Text] [Related]
19. Derivatization of the tricarboxylic acid intermediates with O-benzylhydroxylamine for liquid chromatography-tandem mass spectrometry detection.
Tan B; Lu Z; Dong S; Zhao G; Kuo MS
Anal Biochem; 2014 Nov; 465():134-47. PubMed ID: 25102203
[TBL] [Abstract][Full Text] [Related]
20. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.
Sivaprakasam S; Prasad PD; Singh N
Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
